Document is current
Any future updates will be listed below
-
Authors
Abouarab, Bechara
Bazarian, Christian
Ben Chaouch, Zied http://orcid.org/0000-0001-6130-7696
Lo, Andrew W.
Mourenza Gonzalez, Guillermo
Novak, Richard
Vigneault, Frederic
-
Funding
Funding for this research was provided by:
Laboratory for Financial Engineering
Rockefeller Foundation
Massachusetts Institute of Technology
- License Information
-
More Information
Article History
Received: 16 December 2021
Accepted: 4 June 2023
First Online: 12 September 2023
Declarations
:
: Not applicable.
: Not applicable.
: AWL reports personal investments in private biotechnology companies, biotechnology venture capital funds, and mutual funds. AWL is a co-founder and principal of QLS Advisors LLC, a healthcare investments advisor, and QLS Technologies LLC, a healthcare analytics and consulting company; an advisor to Apricity Health, Aracari Bio, BrightEdge Impact Fund, Enable Medicine, FINRA, Health at Scale, Lazard, MIT Proto Ventures, Quantile Health, Roivant Social Ventures, SalioGen Therapeutics, Swiss Finance Institute, Thalēs, Uncommon Cures, and xCures; and a director of AbCellera, Annual Reviews, Atomwise, BridgeBio Pharma, and Vesalius Therapeutics. During the most recent 6-year period, AWL has received speaking/consulting fees from: AbCellera, AlphaSimplex Group, Annual Reviews, Apricity Health, Aracari Bio, Atomwise, Bernstein Fabozzi Jacobs Levy Award, BridgeBio Pharma, Cambridge Associates, CME, Enable Medicine, Financial Times Prize, Harvard Kennedy School, IMF, Journal of Investment Management, Lazard, National Bank of Belgium, New Frontiers Advisors (for the 2020 Harry M. Markowitz Prize), Oppenheimer, Princeton University Press, Q Group, QLS Advisors, Quantile Health, Research Affiliates, Roivant Sciences, SalioGen, Swiss Finance Institute, and WW Norton. RN is a co-founder, director, and CEO of Unravel Biosciences and a co-founder and director of Rhinostics Inc. FV is a co-founder, director, and CSO of Unravel Biosciences. BA, CB, ZBC, and GM declare that they have no competing interests.
